Advanced Therapies 2021 | Looking forward to the Advanced Therapies Congress & Expo 2021
Sven Kili, MD, Antion Biosciences SA, Geneva, Switzerland, shares his excitement toward the return to in-person congresses while attending the Advanced Therapies Congress & Expo 2021. He discusses the value of having the opportunity to network with other colleagues working in the field of advanced therapies and to learn about the latest scientific advances and breakthroughs made during the COVID-19 pandemic. This interview took place at the Advanced Therapies Congress & Expo 2021.
Disclosures
Sven Kili has the following disclosures:
Antion Biosciences – CEO;
Sven Kili Consulting – Principal;
CCRM – Board Member;
UK Innovation Hubs – Steering Committee Chair;
LGC Corporation – SAB Member;
ISCT – BM&I Committee Chair & 2022 Annual Meeting co-chair;
BIA – CGTAC Chair;
Xintela AB – Board Member;
UCL MSc in Manufacturing & Commercialisation of Cell & Gene Therapes – Steering Committee chair
